← Browse by Condition
Medical Condition

moderate to severe allergic asthma

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT06348407
Recruiting

A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE)

Enrollment
300 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →